Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho

被引:13
作者
Kanda, Eiichiro [1 ,2 ]
Al, Masumi [3 ]
Okazaki, Mitsuyo [4 ]
Yoshida, Masayuki [2 ]
Maeda, Yoshitaka [5 ]
机构
[1] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Grad Sch Med, Dept Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med, Dept Insured Med Care Management, Bunkyo Ku, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Nephrol, Toride, Ibaraki, Japan
关键词
FIBROBLAST GROWTH FACTOR-23; INSULIN-RESISTANCE; PREDIALYSIS PATIENTS; DOWN-REGULATION; RENAL-DISEASE; CHOLESTEROL; RISK; DYSLIPIDEMIA; GENE; METABOLISM;
D O I
10.1371/journal.pone.0166459
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Atherosclerosis is often a complication of chronic kidney disease (CKD) because of dyslipidemia and CKD-mineral and bone disorder. High-density lipoproteins (HDLs) are grouped into various subclasses composed of multiple proteins and lipids, and their transformation is altered in CKD. We investigated the roles of lipoprotein subclasses in CKD progression, and atherosclerosis, and the relationships with Klotho and fibroblast growth factor (FGF) 23. Methods Seventy-one CKD patients were enrolled in this prospective cohort study in Japan. The proportions of cholesterol level to total cholesterol level (cholesterol proportion) and lipoprotein particle numbers in 20 lipoprotein fractions were measured by a newly developed high-performance gel permeation chromatography. Results Diabetic nephropathy was observed in 23.9% of the patients. The mean age was 75.0 years and estimated glomerular filtration rate (eGFR) was 17.2 ml/min./1.73m(2). The lipoprotein particle numbers in small HDLs were higher in Stage 4 group than in Stage 5 group (p = 0.002). Multivariate regression analysis adjusted for baseline characteristics showed that the cholesterol proportions in very small HDLs were associated with eGFR change rate [F19 beta = -17.63, p = 0.036] and ABI [F19 beta = 0.047, p = 0.047] in Stage 4 group, and that serum soluble a-Klotho level was associated with the lipoprotein particle numbers in very small HDLs [F19 beta = 0.00026, p = 0.012; F20 beta = 0.00041, p = 0.036] in Stage 5 group. Conclusions This study showed that HDL subclasses are associated with CKD progression, ABI, and Klotho level in CKD-stage-specific manner.
引用
收藏
页数:18
相关论文
共 49 条
[1]   Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity [J].
Arking, DE ;
Atzmon, G ;
Arking, A ;
Barzilai, N ;
Dietz, HC .
CIRCULATION RESEARCH, 2005, 96 (04) :412-418
[2]   KLOTHO allele status and the risk of early-onset occult coronary artery disease [J].
Arking, DE ;
Becker, DM ;
Yanek, LR ;
Fallin, D ;
Judge, DP ;
Moy, TF ;
Becker, LC ;
Dietz, HC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1154-1161
[3]   Impact of Fibroblast Growth Factor 23 on Lipids and Atherosclerosis in Hemodialysis Patients [J].
Ashikaga, Eijin ;
Honda, Hirokazu ;
Suzuki, Hiroki ;
Hosaka, Nozomu ;
Hirai, Yuki ;
Sanada, Daisuke ;
Nakamura, Mari ;
Nagai, Hisako ;
Matsumoto, Kei ;
Kato, Noriyuki ;
Mukai, Masanori ;
Watanabe, Makoto ;
Takahashi, Keiko ;
Shishido, Kanji ;
Akizawa, Tadao .
THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (03) :315-322
[4]   Dyslipidemia of kidney disease [J].
Attman, Per-Ola ;
Samuelsson, Ola .
CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (04) :293-299
[5]   Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122
[6]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[7]   Serum small-dense LDL abnormalities in chronic renal disease patients [J].
Chu, M. ;
Wang, A. Y. M. ;
Chan, I. H. S. ;
Chui, S. H. ;
Lam, C. W. K. .
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2012, 69 (03) :99-102
[8]   Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation [J].
Deighan, CJ ;
Caslake, MJ ;
McConnell, M ;
Boulton-Jones, JM ;
Packard, CJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) :852-862
[9]   Early chronic kidney disease-mineral bone disorder stimulates vascular calcification [J].
Fang, Yifu ;
Ginsberg, Charles ;
Sugatani, Toshifumi ;
Monier-Faugere, Marie-Claude ;
Malluche, Hartmut ;
Hruska, Keith A. .
KIDNEY INTERNATIONAL, 2014, 85 (01) :142-150
[10]   Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305